Sno-derived RNAs are prevalent molecular markers of cancer immunity
Chow RD, Chen S. Sno-derived RNAs are prevalent molecular markers of cancer immunity. Oncogene 2018, 37: 6442-6462. PMID: 30072739, PMCID: PMC6294694, DOI: 10.1038/s41388-018-0420-z.Peer-Reviewed Original ResearchConceptsCancer immunityCytolytic T cell activityCancer typesHuman cancer immunityTumor immune signatureT cell infiltrationT cell activityTumor immune microenvironmentHuman cancersClinical outcomesImmunosuppressive markersPatient survivalCell infiltrationDistinct cancer typesTumor vasculatureCell activityPatient samplesExpression signaturesImmunityCancerMarkersMolecular markersLike propertiesSdRNAsLarge panelMapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR–mediated direct in vivo screening
Wang G, Chow RD, Ye L, Guzman CD, Dai X, Dong MB, Zhang F, Sharp PA, Platt RJ, Chen S. Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR–mediated direct in vivo screening. Science Advances 2018, 4: eaao5508. PMID: 29503867, PMCID: PMC5829971, DOI: 10.1126/sciadv.aao5508.Peer-Reviewed Original ResearchConceptsTumor suppressorCancer Genome AtlasHuman cancersSgRNA target sitesGenome AtlasCancer Genomics ConsortiumPutative tumor suppressor geneNumerous human cancersTumor suppressor geneCRISPR screensClassical oncogenesGenomics ConsortiumSuppressor geneFunctional variantsFunctional consequencesMutational landscapeAutochthonous mouse modelSuppressorTarget siteAAV-CRISPRGenesMouse liverMultiple variantsLiver tumorigenesisVivo